,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,421,1,3,,17389253,22586,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
1,426,1,2,,17389253,22586,Active,,,,,Cell Viability - Jurkat,Confirmatory,,
2,427,1,1,,17389253,22586,Active,,,,,Cell Viability - Hek293,Confirmatory,,
3,433,1,1,,17389253,22586,Inconclusive,,,,,Cell Viability - HepG2,Confirmatory,,
4,434,1,2,,17389253,22586,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
5,435,1,2,,17389253,22586,Active,,,,,Cell Viability - SK-N-SH,Confirmatory,,
6,445,3,1,,17389253,22586,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
7,530,1,1,,17389253,22586,Inconclusive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
8,540,1,1,,17389253,22586,Active,,,,,Cell Viability - N2a,Confirmatory,,
9,541,1,1,,17389253,22586,Active,,,,,Cell Viability - NIH 3T3,Confirmatory,,
10,542,1,1,,17389253,22586,Inconclusive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
11,543,1,1,,17389253,22586,Active,,,,,Cell Viability - H-4-II-E,Confirmatory,,
12,544,2,1,,17389253,22586,Active,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
13,545,1,1,,17389253,22586,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
14,546,1,1,,17389253,22586,Inconclusive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
15,584,1,3,,17389253,22586,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
16,585,1,4,,17389253,22586,Inconclusive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
17,595,1,3,,17389253,22586,Inconclusive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
18,596,1,2,,17389253,22586,Active,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
19,603,1,2,,17389253,22586,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
20,605,1,2,,17389253,22586,Active,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
21,654,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
22,655,1,1,,17389253,22586,Inconclusive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
23,656,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
24,657,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
25,658,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
26,659,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
27,660,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
28,661,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
29,662,1,1,,17389253,22586,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
30,663,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
31,664,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
32,665,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
33,666,1,1,,17389253,22586,Inconclusive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
34,667,1,1,,17389253,22586,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
35,875,1,2,,17389253,22586,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
36,880,2,1,,17389253,22586,Active,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
37,880,2,1,,17389253,22586,Active,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
38,881,2,2,,17389253,22586,Inconclusive,317373425.0,247.0,0.1995,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
39,884,1,2,,17389253,22586,Active,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
40,885,1,2,,17389253,22586,Inactive,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
41,886,1,2,,17389253,22586,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
42,886,1,2,,17389253,22586,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
43,887,1,2,,17389253,22586,Inconclusive,1832253.0,246.0,15.8489,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
44,889,1,3,,17389253,22586,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
45,892,1,2,,17389253,22586,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
46,893,1,2,,17389253,22586,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
47,893,1,2,,17389253,22586,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
48,894,2,1,,17389253,22586,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
49,900,1,3,,17389253,22586,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
50,902,1,2,,17389253,22586,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
51,912,1,2,,17389253,22586,Inconclusive,21392848.0,,15.8489,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
52,921,1,2,,17389253,22586,Active,,,31.6228,Potency,Cell Viability - LYMP2-001,Confirmatory,,
53,923,1,2,,17389253,22586,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
54,924,1,2,,17389253,22586,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
55,925,1,2,,17389253,22586,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
56,926,1,2,,17389253,22586,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
57,938,1,2,,17389253,22586,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
58,946,1,2,,17389253,22586,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
59,947,1,2,,17389253,22586,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
60,948,1,2,,17389253,22586,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
61,955,1,2,,17389253,22586,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
62,960,1,2,,17389253,22586,Inconclusive,,,0.1585,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
63,961,1,2,,17389253,22586,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
64,962,1,2,,17389253,22586,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
65,963,1,2,,17389253,22586,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
66,964,1,2,,17389253,22586,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
67,965,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-003,Confirmatory,,
68,966,1,2,,17389253,22586,Active,,,39.8107,Potency,Cell Viability - LYMP2-004,Confirmatory,,
69,967,1,2,,17389253,22586,Active,,,39.8107,Potency,Cell Viability - LYMP2-005,Confirmatory,,
70,968,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-009,Confirmatory,,
71,969,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-011,Confirmatory,,
72,970,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-013,Confirmatory,,
73,971,1,2,,17389253,22586,Active,,,39.8107,Potency,Cell Viability - LYMP2-015,Confirmatory,,
74,972,1,2,,17389253,22586,Active,,,39.8107,Potency,Cell Viability - LYMP2-017,Confirmatory,,
75,973,1,2,,17389253,22586,Active,,,39.8107,Potency,Cell Viability - LYMP2-019,Confirmatory,,
76,974,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-021,Confirmatory,,
77,975,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-023,Confirmatory,,
78,976,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-025,Confirmatory,,
79,977,1,2,,17389253,22586,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-002,Confirmatory,,
80,978,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-006,Confirmatory,,
81,979,1,2,,17389253,22586,Active,,,31.6228,Potency,Cell Viability - LYMP2-007,Confirmatory,,
82,980,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-008,Confirmatory,,
83,981,1,2,,17389253,22586,Active,,,31.6228,Potency,Cell Viability - LYMP2-010,Confirmatory,,
84,982,1,2,,17389253,22586,Active,,,39.8107,Potency,Cell Viability - LYMP2-012,Confirmatory,,
85,983,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-014,Confirmatory,,
86,984,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-016,Confirmatory,,
87,985,1,2,,17389253,22586,Active,,,39.8107,Potency,Cell Viability - LYMP2-018,Confirmatory,,
88,986,1,2,,17389253,22586,Active,,,39.8107,Potency,Cell Viability - LYMP2-020,Confirmatory,,
89,987,1,2,,17389253,22586,Active,,,31.6228,Potency,Cell Viability - LYMP2-022,Confirmatory,,
90,988,1,2,,17389253,22586,Active,,,25.1189,Potency,Cell Viability - LYMP2-024,Confirmatory,,
91,989,1,2,,17389253,22586,Active,,,50.1187,Potency,Cell Viability - LYMP2-026,Confirmatory,,
92,993,1,2,,17389253,22586,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
93,994,1,2,,17389253,22586,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
94,995,1,2,,17389253,22586,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
95,1030,2,1,,17389253,22586,Active,30582681.0,216.0,3.1623,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
96,1452,1,1,,17389253,22586,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
97,1457,1,1,,17389253,22586,Inactive,44888968.0,83523.0,15.8489,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
98,1458,1,1,,17389253,22586,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
99,1469,1,1,,17389253,22586,Inconclusive,189491771.0,7068.0,39.8107,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
100,1471,2,1,,17389253,22586,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
101,1476,2,1,,17389253,22586,Active,281307097.0,,7.9433,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
102,1477,1,1,,17389253,22586,Inconclusive,,,28.1838,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
103,1478,2,1,,17389253,22586,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
104,1479,1,2,,17389253,22586,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
105,1948,1,1,,17389253,22586,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
106,1987,1,2,,85148654,22586,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
107,2016,1,3,,85148654,22586,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
108,2023,1,3,,85148654,22586,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
109,2025,1,3,,85148654,22586,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
110,2029,1,3,,85148654,22586,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
111,2052,2,1,,85148654,22586,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
112,2057,1,2,,85148654,22586,Active,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
113,2066,1,4,,85148654,22586,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
114,2099,1,1,,85148654,22586,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
115,2101,1,1,,17389253,22586,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
116,2107,1,1,,17389253,22586,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
117,2112,1,1,,17389253,22586,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
118,2120,1,1,,17389253,22586,Inconclusive,32879895.0,3091.0,39.8107,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
119,2129,1,2,,85148654,22586,Active,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
120,2130,1,3,,85148654,22586,Active,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
121,2171,1,3,,85148654,22586,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
122,2174,1,3,,85148654,22586,Active,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
123,2177,1,3,,85148654,22586,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
124,2233,1,2,,85148654,22586,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
125,2234,1,2,,85148654,22586,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
126,2235,1,2,,85148654,22586,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
127,2280,2,3,,85148654,22586,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
128,2300,1,3,,85148654,22586,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
129,2380,1,2,,85148654,22586,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
130,2391,1,1,,85148654,22586,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
131,2435,1,2,,85148654,22586,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
132,2445,1,2,,85148654,22586,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
133,2462,1,1,,85148654,22586,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
134,2462,1,1,,85148654,22586,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
135,2517,2,1,,17389253,22586,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
136,2517,2,1,,85148654,22586,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
137,2520,1,4,,85148654,22586,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
138,2521,1,3,,85148654,22586,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
139,2524,1,2,,85148654,22586,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
140,2540,1,2,,85148654,22586,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
141,2544,1,2,,85148654,22586,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
142,2546,1,1,,17389253,22586,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
143,2549,1,1,,17389253,22586,Inconclusive,282403581.0,,39.8107,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
144,2551,1,1,,17389253,22586,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
145,2557,1,3,,85148654,22586,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
146,2599,1,2,,85148654,22586,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
147,2606,1,2,,85148654,22586,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
148,2629,1,1,,85148654,22586,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
149,2650,2,1,,85148654,22586,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
150,2661,1,1,,85148654,22586,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
151,2676,1,2,,85148654,22586,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
152,2685,1,1,,85148654,22586,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
153,2690,1,2,,85148654,22586,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
154,2716,1,1,,85148654,22586,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
155,2717,1,2,,85148654,22586,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
156,2718,1,1,,85148654,22586,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
157,2751,2,2,,85148654,22586,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
158,2796,1,4,,85148654,22586,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
159,2797,1,2,,85148654,22586,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
160,2805,2,2,,85148654,22586,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
161,2806,2,2,,85148654,22586,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
162,2825,1,2,,85148654,22586,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
163,434955,1,2,,85148654,22586,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
164,434962,1,2,,85148654,22586,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
165,434973,1,3,,85148654,22586,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
166,434989,1,1,,85148654,22586,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
167,435003,1,3,,85148654,22586,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
168,435005,1,1,,85148654,22586,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
169,435022,2,2,,85148654,22586,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
170,435030,1,2,,85148654,22586,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
171,435030,1,2,,85148654,22586,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
172,449728,1,2,,85148654,22586,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
173,449762,1,2,,85148654,22586,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
174,449763,1,3,,85148654,22586,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
175,463079,1,2,,85148654,22586,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
176,463082,1,1,,85148654,22586,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
177,463104,1,2,,85148654,22586,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
178,463141,1,2,,85148654,22586,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
179,463190,1,2,,85148654,22586,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
180,463195,1,2,,85148654,22586,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
181,463210,1,2,,85148654,22586,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
182,463212,1,1,,85148654,22586,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
183,463254,1,1,,85148654,22586,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
184,485270,1,1,,85148654,22586,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
185,485272,1,1,,85148654,22586,Active,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
186,485273,2,1,,85148654,22586,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
187,485275,1,3,,85148654,22586,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
188,485290,1,1,,17389253,22586,Inactive,20150581.0,,14.1254,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
189,485290,1,1,,85148654,22586,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
190,485294,1,1,,85148654,22586,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
191,485297,1,1,,85148654,22586,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
192,485298,1,1,,85148654,22586,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
193,485313,1,2,,85148654,22586,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
194,485317,1,2,,85148654,22586,Inconclusive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
195,485341,1,1,,85148654,22586,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
196,485344,1,1,,85148654,22586,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
197,485346,1,1,,85148654,22586,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
198,485346,1,1,,85148654,22586,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
199,485347,1,2,,85148654,22586,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
200,485349,1,1,,85148654,22586,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
201,485353,2,1,,85148654,22586,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
202,485358,1,1,,85148654,22586,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
203,485360,1,1,,85148654,22586,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
204,485364,1,1,,85148654,22586,Active,15149312.0,8345881.0,1.9953,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
205,485367,1,2,,85148654,22586,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
206,488837,1,1,,85148654,22586,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
207,488847,1,3,,85148654,22586,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
208,488890,1,2,,85148654,22586,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
209,489030,2,1,,85148654,22586,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
210,489031,2,1,,85148654,22586,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
211,492947,1,1,,85148654,22586,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
212,493011,1,1,,85148654,22586,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
213,493012,1,1,,85148654,22586,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
214,493014,1,1,,85148654,22586,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
215,493036,1,2,,85148654,22586,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
216,493056,1,1,,85148654,22586,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
217,493084,1,1,,85148654,22586,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
218,504327,1,1,,85148654,22586,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
219,504332,1,1,,85148654,22586,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
220,504333,1,1,,85148654,22586,Active,6683500.0,29994.0,6.3096,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
221,504339,1,1,,17389253,22586,Inconclusive,162330054.0,,8.9125,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
222,504406,1,1,,85148654,22586,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
223,504444,1,1,,17389253,22586,Inconclusive,224028257.0,4780.0,11.5821,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
224,504466,1,1,,85148654,22586,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
225,504467,1,1,,85148654,22586,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
226,504648,1,1,,17389253,22586,Inconclusive,,,20.5962,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
227,504651,1,1,,85148654,22586,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
228,504660,1,1,,85148654,22586,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
229,504706,1,1,,85148654,22586,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
230,504810,1,2,,85148654,22586,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
231,504812,1,2,,85148654,22586,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
232,504832,1,1,,85148654,22586,Inconclusive,,,16.5113,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
233,504834,1,1,,85148654,22586,Inconclusive,,,11.6891,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
234,504842,1,1,,85148654,22586,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
235,504845,1,1,,17389253,22586,Inconclusive,86301163.0,5999.0,11.2202,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
236,504847,1,1,,17389253,22586,Inconclusive,63054845.0,7421.0,56.2341,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
237,504891,1,1,,17389253,22586,Inconclusive,5453898.0,5300.0,56.2341,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
238,540267,1,1,,17389253,22586,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
239,540275,1,1,,85148654,22586,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
240,540277,1,1,,85148654,22586,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
241,540317,1,1,,17389253,22586,Active,187960037.0,10951.0,11.2202,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
242,588342,1,1,,85148654,22586,Inconclusive,160794.0,,13.4591,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
243,588453,1,1,,17389253,22586,Inconclusive,8659577.0,58819.0,56.2341,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
244,588456,1,1,,17389253,22586,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
245,588513,1,1,,17389253,22586,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
246,588514,1,1,,17389253,22586,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
247,588515,1,1,,17389253,22586,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
248,588516,1,1,,17389253,22586,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
249,588526,1,1,,17389253,22586,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
250,588527,1,1,,17389253,22586,Inconclusive,325495553.0,9971.0,31.6228,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
251,588532,1,1,,17389253,22586,Inconclusive,311348376.0,2908.0,4.4668,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
252,588533,1,1,,17389253,22586,Inconclusive,311348376.0,2908.0,79.4328,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
253,588534,1,1,,17389253,22586,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
254,588535,1,1,,17389253,22586,Inconclusive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
255,588536,1,1,,17389253,22586,Inconclusive,216409692.0,5468.0,31.6228,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
256,588537,1,1,,17389253,22586,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
257,588541,1,1,,17389253,22586,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
258,588543,1,1,,17389253,22586,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
259,588544,1,1,,17389253,22586,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
260,588545,1,1,,17389253,22586,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
261,588546,1,1,,17389253,22586,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
262,588547,1,1,,17389253,22586,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
263,588579,1,1,,17389253,22586,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
264,588590,1,1,,17389253,22586,Active,154350220.0,11201.0,19.9526,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
265,588795,1,1,,17389253,22586,Inconclusive,4758356.0,2237.0,2.8184,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
266,588812,1,1,,17389253,22586,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
267,588812,1,1,1.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
268,588812,1,1,2.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
269,588812,1,1,3.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
270,588812,1,1,4.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
271,588812,1,1,5.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
272,588812,1,1,6.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
273,588812,1,1,7.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
274,588812,1,1,8.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
275,588812,1,1,9.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
276,588812,1,1,10.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
277,588812,1,1,11.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
278,588812,1,1,12.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
279,588812,1,1,13.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
280,588812,1,1,14.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
281,588812,1,1,15.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
282,588812,1,1,16.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
283,588812,1,1,17.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
284,588812,1,1,18.0,17389253,22586,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
285,588812,1,1,19.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
286,588812,1,1,20.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
287,588812,1,1,21.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
288,588812,1,1,22.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
289,588812,1,1,23.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
290,588812,1,1,24.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
291,588812,1,1,25.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
292,588812,1,1,26.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
293,588812,1,1,27.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
294,588812,1,1,28.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
295,588812,1,1,29.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
296,588812,1,1,30.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
297,588812,1,1,31.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
298,588812,1,1,32.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
299,588812,1,1,33.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
300,588812,1,1,34.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
301,588812,1,1,35.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
302,588812,1,1,36.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
303,588812,1,1,37.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
304,588812,1,1,38.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
305,588812,1,1,39.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
306,588812,1,1,40.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
307,588812,1,1,41.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
308,588812,1,1,42.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
309,588812,1,1,43.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
310,588812,1,1,44.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
311,588812,1,1,45.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
312,588812,1,1,46.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
313,588812,1,1,47.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
314,588812,1,1,48.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
315,588812,1,1,49.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
316,588812,1,1,50.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
317,588812,1,1,51.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
318,588812,1,1,52.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
319,588812,1,1,53.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
320,588812,1,1,54.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
321,588812,1,1,55.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
322,588812,1,1,56.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
323,588812,1,1,57.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
324,588812,1,1,58.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
325,588812,1,1,59.0,17389253,22586,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
326,588812,1,1,60.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
327,588812,1,1,61.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
328,588812,1,1,62.0,17389253,22586,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
329,588812,1,1,63.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
330,588812,1,1,64.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
331,588812,1,1,65.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
332,588812,1,1,66.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
333,588812,1,1,67.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
334,588812,1,1,68.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
335,588812,1,1,69.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
336,588812,1,1,70.0,17389253,22586,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
337,588812,1,1,71.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
338,588812,1,1,72.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
339,588812,1,1,73.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
340,588812,1,1,74.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
341,588812,1,1,75.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
342,588812,1,1,76.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
343,588812,1,1,77.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
344,588812,1,1,78.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
345,588812,1,1,79.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
346,588812,1,1,80.0,17389253,22586,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
347,588812,1,1,81.0,17389253,22586,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
348,588813,1,1,,17389253,22586,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
349,588813,1,1,1.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
350,588813,1,1,2.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
351,588813,1,1,3.0,17389253,22586,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
352,588813,1,1,4.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
353,588813,1,1,5.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
354,588813,1,1,6.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
355,588813,1,1,7.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
356,588813,1,1,8.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
357,588813,1,1,9.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
358,588813,1,1,10.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
359,588813,1,1,11.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
360,588813,1,1,12.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
361,588813,1,1,13.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
362,588813,1,1,14.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
363,588813,1,1,15.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
364,588813,1,1,16.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
365,588813,1,1,17.0,17389253,22586,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
366,588813,1,1,18.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
367,588813,1,1,19.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
368,588813,1,1,20.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
369,588813,1,1,21.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
370,588813,1,1,22.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
371,588813,1,1,23.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
372,588813,1,1,24.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
373,588813,1,1,25.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
374,588813,1,1,26.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
375,588813,1,1,27.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
376,588813,1,1,28.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
377,588813,1,1,29.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
378,588813,1,1,30.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
379,588813,1,1,31.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
380,588813,1,1,32.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
381,588813,1,1,33.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
382,588813,1,1,34.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
383,588813,1,1,35.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
384,588813,1,1,36.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
385,588813,1,1,37.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
386,588813,1,1,38.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
387,588813,1,1,39.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
388,588813,1,1,40.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
389,588813,1,1,41.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
390,588813,1,1,42.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
391,588813,1,1,43.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
392,588813,1,1,44.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
393,588813,1,1,45.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
394,588813,1,1,46.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
395,588813,1,1,47.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
396,588813,1,1,48.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
397,588813,1,1,49.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
398,588813,1,1,50.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
399,588813,1,1,51.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
400,588813,1,1,52.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
401,588813,1,1,53.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
402,588813,1,1,54.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
403,588813,1,1,55.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
404,588813,1,1,56.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
405,588813,1,1,57.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
406,588813,1,1,58.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
407,588813,1,1,59.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
408,588813,1,1,60.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
409,588813,1,1,61.0,17389253,22586,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
410,588813,1,1,62.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
411,588813,1,1,63.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
412,588813,1,1,64.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
413,588813,1,1,65.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
414,588813,1,1,66.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
415,588813,1,1,67.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
416,588813,1,1,68.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
417,588813,1,1,69.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
418,588813,1,1,70.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
419,588813,1,1,71.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
420,588813,1,1,72.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
421,588813,1,1,73.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
422,588813,1,1,74.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
423,588813,1,1,75.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
424,588813,1,1,76.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
425,588813,1,1,77.0,17389253,22586,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
426,588813,1,1,78.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
427,588813,1,1,79.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
428,588813,1,1,80.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
429,588813,1,1,81.0,17389253,22586,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
430,588834,2,1,,17389253,22586,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
431,588855,1,1,,17389253,22586,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
432,588856,1,1,,17389253,22586,Inactive,,,6.3096,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
433,602310,1,2,,17389253,22586,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
434,602332,1,1,,17389253,22586,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
435,624178,1,1,,17389253,22586,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
436,624202,1,1,,17389253,22586,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
437,624263,1,1,,17389253,22586,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
438,624263,1,1,,17389253,22586,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
439,624414,1,1,,17389253,22586,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
440,651631,4,1,,144207542,22586,Inconclusive,269849759.0,7157.0,54.2058,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
441,651632,4,1,,144207542,22586,Inconclusive,296439460.0,79915.0,9.6393,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
442,651633,4,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
443,651634,4,1,,144207542,22586,Active,,,27.1672,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
444,651741,1,1,,17389253,22586,Inconclusive,20149576.0,4780.0,66.8242,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
445,651743,1,1,,17389253,22586,Inconclusive,269849759.0,7157.0,44.6684,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
446,651749,1,1,,17389253,22586,Inconclusive,34577122.0,4790.0,31.6228,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
447,651751,1,1,,17389253,22586,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
448,651754,1,1,,17389253,22586,Inconclusive,,,42.1632,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
449,651755,1,1,,17389253,22586,Inconclusive,,,42.1632,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
450,651757,1,1,,17389253,22586,Inconclusive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
451,651758,1,1,,17389253,22586,Inconclusive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
452,651777,1,1,,17389253,22586,Inconclusive,51095037.0,196.0,44.6684,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
453,651778,1,1,,17389253,22586,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
454,651802,1,1,,17389253,22586,Active,49066040.0,6097.0,21.1317,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
455,651820,1,1,,85148654,22586,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
456,651838,1,1,,17389253,22586,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
457,651838,1,1,1.0,17389253,22586,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
458,651838,1,1,2.0,17389253,22586,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
459,651838,1,1,3.0,17389253,22586,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
460,651838,1,1,4.0,17389253,22586,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
461,651838,1,1,5.0,17389253,22586,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
462,651838,1,1,6.0,17389253,22586,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
463,651838,1,1,7.0,17389253,22586,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
464,651838,1,1,8.0,17389253,22586,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
465,651965,1,1,,17389253,22586,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
466,652106,1,1,,17389253,22586,Inactive,586067.0,6622.0,12.5893,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
467,686978,1,1,,17389253,22586,Active,79154014.0,55775.0,3.1623,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
468,686979,1,1,,17389253,22586,Active,79154014.0,55775.0,5.0119,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
469,720516,2,1,,144207542,22586,Active,296439460.0,79915.0,10.8155,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
470,720552,2,1,,144207542,22586,Inconclusive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
471,720579,2,1,,17389253,22586,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
472,720580,1,1,,17389253,22586,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
473,720634,2,1,,144207542,22586,Inconclusive,,,30.4821,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
474,720635,2,1,,144207542,22586,Active,,,6.8241,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
475,720636,1,1,,17389253,22586,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
476,720637,2,1,,144207542,22586,Active,,,7.65677,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
477,720652,1,1,,17389253,22586,Inconclusive,,,42.1632,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
478,720653,1,1,,17389253,22586,Inconclusive,,,31.6228,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
479,720659,1,1,,17389253,22586,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
480,720674,2,2,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
481,720675,2,2,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
482,720678,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
483,720679,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
484,720680,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
485,720681,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
486,720682,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
487,720683,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
488,720684,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
489,720685,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
490,720686,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
491,720687,2,2,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
492,720691,4,1,,144207542,22586,Inconclusive,311348376.0,2908.0,24.4362,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
493,720692,3,1,,144207542,22586,Inconclusive,311348376.0,2908.0,48.7566,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
494,720693,3,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
495,720719,2,1,,144207542,22586,Inconclusive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
496,720725,2,1,,144207542,22586,Active,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
497,743012,3,1,,144207542,22586,Active,,,15.2773,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
498,743014,3,1,,144207542,22586,Active,,,13.6159,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
499,743015,3,1,,144207542,22586,Active,,,13.6159,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
500,743033,3,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
501,743035,2,1,,144207542,22586,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
502,743036,2,1,,144207542,22586,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
503,743040,3,1,,144207542,22586,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
504,743041,3,1,,144207542,22586,Inconclusive,,,60.8199,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
505,743042,3,1,,144207542,22586,Inconclusive,124375976.0,367.0,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
506,743053,2,1,,144207542,22586,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
507,743054,2,1,,144207542,22586,Inconclusive,124375976.0,367.0,25.6475,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
508,743063,2,1,,144207542,22586,Inconclusive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
509,743064,3,1,,144207542,22586,Active,,,12.1352,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
510,743065,3,1,,144207542,22586,Active,399498506.0,24831.0,7.6568,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
511,743066,3,1,,144207542,22586,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
512,743067,2,1,,144207542,22586,Inconclusive,399498506.0,24831.0,8.59103,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
513,743069,2,1,,144207542,22586,Inconclusive,348019627.0,2099.0,24.4362,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
514,743074,2,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
515,743075,2,1,,144207542,22586,Inconclusive,348019627.0,2099.0,0.1941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
516,743077,2,1,,144207542,22586,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
517,743078,2,1,,144207542,22586,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
518,743079,3,1,,144207542,22586,Inactive,348019627.0,2099.0,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
519,743080,3,1,,144207542,22586,Inconclusive,348019627.0,2099.0,68.241,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
520,743081,3,1,,144207542,22586,Active,,,54.2058,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
521,743083,3,1,,144207542,22586,Active,119597822.0,1588.0,27.1672,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
522,743084,3,1,,144207542,22586,Active,,,24.2128,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
523,743085,3,1,,144207542,22586,Inconclusive,51095037.0,196.0,38.3747,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
524,743086,3,1,,144207542,22586,Inconclusive,,,48.3109,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
525,743091,2,1,,144207542,22586,Inconclusive,348019627.0,2099.0,54.2058,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
526,743094,3,1,,144207542,22586,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
527,743122,2,1,,144207542,22586,Active,51095037.0,196.0,27.1672,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
528,743139,2,1,,144207542,22586,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
529,743140,2,1,,144207542,22586,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
530,743191,3,1,,144207542,22586,Inconclusive,216409692.0,5468.0,6.8871,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
531,743194,3,1,,144207542,22586,Active,,,12.2471,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
532,743199,2,1,,144207542,22586,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
533,743202,4,1,,144207542,22586,Inconclusive,20149576.0,4780.0,7.6568,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
534,743203,3,1,,144207542,22586,Inconclusive,,,48.3109,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
535,743209,3,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
536,743210,4,1,,144207542,22586,Inconclusive,4504517.0,3315.0,13.7415,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
537,743211,3,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
538,743212,3,1,,144207542,22586,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
539,743213,3,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
540,743215,3,1,,144207542,22586,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
541,743217,3,1,,144207542,22586,Inconclusive,325495553.0,9971.0,3.0763,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
542,743218,3,1,,144207542,22586,Inconclusive,,,4.3454,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
543,743219,3,1,,144207542,22586,Inconclusive,20149576.0,4780.0,5.0201,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
544,743220,3,1,,144207542,22586,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
545,743221,3,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
546,743222,3,1,,144207542,22586,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
547,743223,3,1,,144207542,22586,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
548,743224,3,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
549,743225,3,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
550,743226,2,1,,144207542,22586,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
551,743227,2,1,,144207542,22586,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
552,743228,3,1,,144207542,22586,Active,4504517.0,3315.0,7.43647,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
553,743239,2,1,,144207542,22586,Inconclusive,325495553.0,9971.0,6.13809,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
554,743240,2,1,,144207542,22586,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
555,743241,2,1,,144207542,22586,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
556,743242,2,1,,144207542,22586,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
557,743288,1,1,,17389253,22586,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
558,743292,1,1,,17389253,22586,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
559,1159509,1,1,,144207542,22586,Inconclusive,119626539.0,4790.0,43.4544,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
560,1159515,1,1,,144207542,22586,Inconclusive,,,54.7058,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
561,1159516,1,1,,144207542,22586,Inconclusive,119611100.0,22926.0,38.7287,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
562,1159517,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
563,1159518,1,1,,144207542,22586,Inconclusive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
564,1159519,1,1,,144207542,22586,Inconclusive,119611100.0,22926.0,52.6462,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
565,1159520,1,1,,144207542,22586,Inconclusive,,,34.2015,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
566,1159521,1,1,,144207542,22586,Inconclusive,15928672.0,19885.0,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
567,1159523,1,1,,144207542,22586,Inconclusive,15928672.0,19885.0,19.2329,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
568,1159525,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
569,1159526,1,1,,144207542,22586,Inconclusive,119627033.0,3725.0,34.516999999999996,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
570,1159527,1,1,,144207542,22586,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
571,1159528,1,1,,144207542,22586,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
572,1159529,1,1,,144207542,22586,Inconclusive,,,24.4362,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
573,1159531,1,1,,144207542,22586,Inconclusive,325495497.0,6256.0,9.72822,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
574,1159551,1,1,,144207542,22586,Inconclusive,,,68.241,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
575,1159552,1,1,,144207542,22586,Inactive,325495463.0,5914.0,9.6393,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
576,1159553,2,1,,144207542,22586,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
577,1159555,1,1,,144207542,22586,Inconclusive,325495463.0,5914.0,9.6393,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
578,1224834,3,1,,144207542,22586,Active,,,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
579,1224835,1,1,,144207542,22586,Active,160794.0,,63.0029,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
580,1224836,1,1,,144207542,22586,Inconclusive,,,54.2058,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
581,1224837,1,1,,144207542,22586,Inconclusive,,,54.2058,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
582,1224838,1,1,,144207542,22586,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
583,1224839,1,1,,144207542,22586,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
584,1224840,3,1,,144207542,22586,Active,,,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
585,1224841,3,1,,144207542,22586,Active,325495545.0,2101.0,15.2773,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
586,1224842,3,1,,144207542,22586,Inactive,325495545.0,2101.0,13.6159,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
587,1224843,1,1,,144207542,22586,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
588,1224844,1,1,,144207542,22586,Active,,,24.4362,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
589,1224845,1,1,,144207542,22586,Inconclusive,344243002.0,100757539.0,56.3948,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
590,1224846,1,1,,144207542,22586,Inconclusive,11995455.0,3091.0,48.7566,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
591,1224847,1,1,,144207542,22586,Active,,,89.3797,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
592,1224848,3,1,,144207542,22586,Active,325495545.0,2101.0,19.2329,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
593,1224849,3,1,,144207542,22586,Inactive,325495545.0,2101.0,17.1414,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
594,1224867,1,1,,144207542,22586,Active,,,48.7566,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
595,1224868,1,1,,144207542,22586,Active,,,19.4104,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
596,1224869,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
597,1224870,1,1,,144207542,22586,Inconclusive,,,54.7058,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
598,1224871,1,1,,144207542,22586,Active,,,24.4362,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
599,1224872,1,1,,144207542,22586,Active,,,24.4362,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
600,1224873,1,1,,144207542,22586,Active,,,43.4544,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
601,1224874,1,1,,144207542,22586,Active,,,19.4104,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
602,1224875,1,1,,144207542,22586,Inconclusive,,,54.7058,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
603,1224876,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
604,1224877,1,1,,144207542,22586,Inconclusive,,,54.7058,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
605,1224878,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
606,1224879,1,1,,144207542,22586,Inconclusive,,,54.7058,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
607,1224880,1,1,,144207542,22586,Inconclusive,,,13.7415,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
608,1224881,1,1,,144207542,22586,Active,,,43.4544,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
609,1224882,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
610,1224883,1,1,,144207542,22586,Inconclusive,,,61.3809,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
611,1224884,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
612,1224885,1,1,,144207542,22586,Active,,,48.7566,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
613,1224886,1,1,,144207542,22586,Active,,,24.4362,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
614,1224887,1,1,,144207542,22586,Active,,,21.7788,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
615,1224888,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
616,1224889,1,1,,144207542,22586,Inconclusive,,,43.4544,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
617,1224890,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
618,1224892,1,1,,144207542,22586,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
619,1224893,1,1,,144207542,22586,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
620,1224894,1,1,,144207542,22586,Inconclusive,11995455.0,3091.0,48.7566,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
621,1224895,1,1,,144207542,22586,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
622,1224896,1,1,,144207542,22586,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
623,1259241,1,1,,144207542,22586,Active,,,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
624,1259242,1,1,,144207542,22586,Active,,,48.3109,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
625,1259243,1,1,,144207542,22586,Active,124375976.0,367.0,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
626,1259244,1,1,,144207542,22586,Inconclusive,348019627.0,2099.0,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
627,1259247,1,1,,144207542,22586,Inconclusive,124375976.0,367.0,21.5797,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
628,1259248,1,1,,144207542,22586,Inconclusive,348019627.0,2099.0,36.93,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
629,1259364,1,1,,144207542,22586,Inconclusive,1013403374.0,9734.0,54.2058,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
630,1259365,1,1,,144207542,22586,Inconclusive,,,48.3109,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
631,1259366,1,1,,144207542,22586,Active,,,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
632,1259367,1,1,,144207542,22586,Active,,,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
633,1259368,1,1,,144207542,22586,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
634,1259369,1,1,,144207542,22586,Inconclusive,109731339.0,2737.0,9.6393,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
635,1259377,1,1,,144207542,22586,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
636,1259378,1,1,,144207542,22586,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
637,1259379,1,1,,144207542,22586,Active,,,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
638,1259380,1,1,,144207542,22586,Active,,,27.1672,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
639,1259381,1,1,,144207542,22586,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
640,1259382,1,1,,144207542,22586,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
641,1259383,1,1,,144207542,22586,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
642,1259384,1,1,,144207542,22586,Inconclusive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
643,1259385,1,1,,144207542,22586,Inconclusive,119601739.0,7253.0,24.2128,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
644,1259386,1,1,,144207542,22586,Active,,,30.4821,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
645,1259387,1,1,,144207542,22586,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
646,1259388,1,1,,144207542,22586,Inconclusive,1013403374.0,9734.0,51.1735,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
647,1259390,1,1,,144207542,22586,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
648,1259391,1,1,,144207542,22586,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
649,1259392,1,1,,144207542,22586,Inconclusive,109731339.0,2737.0,19.9854,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
650,1259393,1,1,,144207542,22586,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
651,1259394,1,1,,144207542,22586,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
652,1259395,1,1,,144207542,22586,Inconclusive,119601739.0,7253.0,68.241,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
653,1259396,1,1,,144207542,22586,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
654,1259401,1,1,,144207542,22586,Inconclusive,325495545.0,2101.0,22.4239,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
655,1259402,1,1,,144207542,22586,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
656,1259403,1,1,,144207542,22586,Inconclusive,325495545.0,2101.0,22.4239,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
657,1259404,1,1,,144207542,22586,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
658,1259407,1,1,,363903910,22586,Active,,,,,CCRIS mutagenicity studies,Other,,
